Helle Kieler
Overview
Explore the profile of Helle Kieler including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
141
Citations
2134
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rodriguez-Wallberg K, Kieler H, Foukakis T, Li J, Gissler M, Oberg A, et al.
EClinicalMedicine
. 2024 Feb;
67:102335.
PMID: 38314058
Background: Worldwide, an increasing number of women with cancer are receiving Gonadotropin Releasing Hormone agonist (GnRHa) co-treatment during chemotherapy aiming at ovarian protection. There is divergence among guidelines, and some...
2.
Giunta D, Karlsson P, Younus M, Berglind I, Kieler H, Reutfors J
BMC Gastroenterol
. 2024 Jan;
24(1):21.
PMID: 38182992
Background: Liver disorders are important adverse effects associated with antifungal drug treatment. However, the accuracy of Clinical International Classification of Diseases (ICD)-10 codes in identifying liver disorders for register based...
3.
Odsbu I, Handal M, Hjellvik V, Hernandez-Diaz S, Kieler H, Norgaard M, et al.
Front Pharmacol
. 2023 May;
14:1056192.
PMID: 37214456
Opioids may modulate the immune function through opioid receptors on immune cells. Long-term consequences of prenatal opioid exposure on the immune system, such as childhood asthma, are unknown. To investigate...
4.
Dudukina E, Szepligeti S, Karlsson P, Asomaning K, Daltveit A, Hakkarainen K, et al.
Drug Saf
. 2023 Apr;
46(7):661-675.
PMID: 37099261
Introduction: Pregabalin is an antiepileptic drug frequently prescribed to pregnant women. Risks of adverse birth and postnatal neurodevelopmental outcomes following prenatal exposure to pregabalin are uncertain. Objective: To investigate the...
5.
Broms G, Hernandez-Diaz S, Huybrechts K, Bateman B, Kristiansen E, Einarsdottir K, et al.
J Clin Psychiatry
. 2023 Jan;
84(1).
PMID: 36652686
Most research on safety of attention-deficit/hyperactivity disorder (ADHD) medications during pregnancy concerns central nervous system stimulants, while little is known about the safety of atomoxetine, a primary treatment alternative. We...
6.
Nakitanda A, Kieler H, Odsbu I, Rhedin S, Almqvist C, Pasternak B, et al.
Am J Obstet Gynecol MFM
. 2023 Jan;
5(4):100860.
PMID: 36626967
Background: Prenatal antibiotic use, the ensuing maternal dysbiosis, and subsequent acquisition of altered microbiota in early life have been linked to the offspring's increased susceptibility to childhood infections. However, infection...
7.
Huybrechts K, Straub L, Karlsson P, Pazzagli L, Furu K, Gissler M, et al.
JAMA Psychiatry
. 2022 Dec;
80(2):156-166.
PMID: 36477338
Importance: Psychiatric disorders are common among female individuals of reproductive age. While antipsychotic medication use is increasing, the safety of such medications in pregnancy is an area with large evidence...
8.
Yagi T, Mannheimer B, Reutfors J, Ursing J, Giunta D, Kieler H, et al.
Br J Clin Pharmacol
. 2022 Sep;
89(2):887-897.
PMID: 36098510
Fluoroquinolones and macrolides may, due to a potential drug-drug interaction, increase the concentration of any concomitantly administered direct oral anticoagulant (DOAC) and thereby increase the risk of severe bleeding. However,...
9.
Pazzagli L, Segovia Chacon S, Karampelias C, Cohen J, Broms G, Kieler H, et al.
PLoS One
. 2022 Aug;
17(8):e0272046.
PMID: 35951607
Introduction: Inconsistent results have been reported on the association between folic acid use in pregnancy and risk of GDM. The aim of this study was to estimate the association between...
10.
Kopp-Kallner H, Linder M, Cesta C, Segovia Chacon S, Kieler H, Graner S
Obstet Gynecol
. 2022 May;
139(5):764-770.
PMID: 35576335
Objective: To estimate the incidence rates for ectopic pregnancy by contraceptive method in a cohort of women using hormonal contraception in Sweden between 2005 and 2016. Method: Women aged 15-49...